{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-272592","form_type":"8-K","ticker":"GH","cik":"0001576280","company_name":"Guardant Health, Inc.","filed_at":"2025-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.801856+00:00","generated_at":"2026-05-16T23:03:11.734642+00:00","sec_items":["1.01","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Guardant Health raises ~$717M via upsized equity and convertible debt offerings","bullets":["Public offering of 3,833,332 shares at $90/share (incl. underwriter option), net proceeds ~$327.2M.","Convertible notes: $402.5M principal, 0% coupon, due 2033, conversion price ~$121.50/share (35% premium).","Net proceeds from notes ~$390M; combined ~$717M for general corporate purposes, including possible 2027 note repurchase.","Both offerings upsized from initially announced amounts ($250M equity, $300M notes); closed Nov 7, 2025.","Notes convertible under certain conditions after Feb 15, 2033; redeemable after Nov 20, 2029."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-272592","json":"https://secwatch.observer/filing/0001193125-25-272592.json","markdown":"https://secwatch.observer/filing/0001193125-25-272592.md","text":"https://secwatch.observer/filing/0001193125-25-272592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576280/000119312525272592/0001193125-25-272592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576280/000119312525272592/d66171d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:03:11.734642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c5ec1e0b81c439cb05c9ed7932db450d5575596","claim":"Guardant Health, Inc. incurred convertible notes of $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 with U.S. Bank Trust Company, National Association at 0.00% maturing May 15, 2033.","evidence_excerpt":"On November 7, 2025, the Company completed its previously announced private offering (the “Convertible Notes Offering”) of $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to an additional $52.5 million principal amount of Notes.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1576280/000119312525272592/0001193125-25-272592-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2033"},{"label":"Counterparty","value":"U.S. Bank Trust Company, National Association"},{"label":"Rate","value":"0.00%"},{"label":"Maturity","value":"May 15, 2033"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}